Targeting IL-23 for IBD: Rationale and Progress to Date. Vuyyuru SK, Shackelton LM, Hanzel J, Ma C, et al. Drugs 2023;83:873-891.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vuyyuru SK, Shackelton LM, Hanzel J, Ma C, et al. Targeting IL-23 for IBD: Rationale and Progress to Date. Drugs 2023;83:873-891.
PMID: 37266801